ASCO 2021

Luminal Breast Cancer: Prognostic Impact of Recurrence Score, Endocrine Response, and Other Factors

Nadia Harbeck, MD, PhD

Luminal Breast Cancer: Prognostic Impact of Recurrence Score, Endocrine Response, and Other Factors [mehr...]
 

Early Breast Cancer: Benefit of a De-escalated Regimen

Nadia Harbeck, MD, PhD

Early Breast Cancer: Benefit of a De-escalated Regimen [mehr...]
 

Expert Perspective on De-escalating Breast Cancer Therapy With Paclitaxel, Pertuzumab, and Trastuzumab

Nadia Harbeck, MD, PhD

Expert Perspective on De-escalating Breast Cancer Therapy With Paclitaxel, Pertuzumab, and Trastuzumab [mehr...]